Markus Krumme

USPTO Granted Patents = 34 (Patent Applications = 2)

CIPO Patents = 8

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 1.8

ph-index = 7

Forward Citations = 261(Granted Patents)

Location History:

Denville, NJ (US) (2014 - 2015)
Randolph, NJ (US) (2007 - 2017)
Neuwied, DE (2004 - 2021)
Allschwil, CH (2015 - 2023)

Company Filing History:

33 out of 319

Lts Lohmann Therapie-systeme Ag

Santhera Pharmaceuticals (schweitz) Ag

patent

where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11642315 - Method for preparing a pharmaceutical product (2023-05-09),

2. 11497811 - Wafer and capsule formulations with enhanced dissolution rates for fenofibrate (2022-11-15),

3. 11045387 - Tightly sealing single dose packaging (2021-06-29),

4. 10806703 - Transmucosal administration system for a pharmaceutical drug (2020-10-20),

5. 10744176 - Edible oral strip or wafer dosage form containing ion exchange resin for taste masking (2020-08-18),

6. 10716762 - Transmucosal administration system for a pharmaceutical drug (2020-07-21),

7. 10398746 - Edible oral strip or wafer dosage form containing ion exchange resin for taste masking (2019-09-03),

8. 9849184 - Wafer and capsule formulations with enhanced dissolution rates for fenofibrate (2017-12-26),

9. 9763960 - Wafer comprising steroid hormones (2017-09-19),

10. 9637293 - Childproof highly-inert packaging for individually dosed films containing an active ingredient (2017-05-02),

11. 9597852 - Childproof, highly inert individual packaging (2017-03-21),

12. 9597287 - Edible oral strip or wafer dosage form containing ion exchange resin for taste masking (2017-03-21),

13. 9493285 - Stackable bag packaging (2016-11-15),

14. 9370463 - Childproof highly-inert packaging for individually dosed films containing an active ingredient (2016-06-21),

15. 9211991 - Packaging for active substance-containing films and method for producing them (2015-12-15),

Title: Innovations of Markus Krumme in Pharmaceutical Development

Introduction

Markus Krumme, an accomplished inventor based in Neuwied, Germany, has a remarkable portfolio of 34 patents. His work primarily focuses on improvements in pharmaceutical products, particularly through novel formulations and methods. Krumme's contributions play a significant role in enhancing the efficiency and effectiveness of drug delivery systems.

Latest Patents

Among his latest innovations are two notable patents. The first patent is a detailed method for preparing a pharmaceutical product, which involves a systematic approach to using a neat active pharmaceutical ingredient (API). This method includes several parameters determined by a FT4 powder rheometer, ensuring the quality and performance of the drug formulation.

The second patent focuses on wafer and capsule formulations with enhanced dissolution rates for fenofibrate. This invention addresses the challenges of fenofibrate, a compound known for its difficulty in dissolving and controlling its release rate in vitro. The formulation comprises multiple ingredients, including fenofibrate, surfactants, and carrier materials, resulting in improved drug delivery and patient compliance.

Career Highlights

Throughout his career, Markus Krumme has made significant strides in the pharmaceutical sector. He has worked for established companies such as LTS Lohmann Therapie-Systeme AG and Santhera Pharmaceuticals (Schweiz) AG, where he applied his expertise in innovative pharmaceutical technologies. His dedication to research and development has established him as a prominent figure in the industry.

Collaborations

In his pursuit of innovation, Krumme has collaborated with colleagues such as Karin Ludwig and Christian Von Falkenhausen. These collaborations have fostered a supportive environment for creativity and advancement within the realm of pharmaceutical development.

Conclusion

Markus Krumme's contributions to the pharmaceutical field through his patents have demonstrated his commitment to improving drug delivery systems. His innovative methods and formulations exemplify the importance of research and development in creating effective pharmaceutical products. As he continues to make strides in this field, his work will undoubtedly impact the future of medicine.

This text is generated by artificial intelligence and may not be accurate.